The Effect of Health Belief Model-Based Cancer Education on Cancer Information Load, Knowledge and Attitudes Towards Cancer Screenings
1 other identifier
interventional
79
1 country
1
Brief Summary
Participants will be randomly assigned to the experimental and control groups. The study will involve a total of 78 participants, with 39 in the experimental group and 39 in the control group. The 39 participants assigned to the experimental group will first complete the cancer knowledge burden, and attitudes and information about cancer screenings scales. They will then receive cancer education consisting of four modules, which will be completed over four weeks. At the end of these four weeks, they will complete the scales again. One month after the education, the experimental group will complete the scales once more for follow-up monitoring. The control group will first complete the cancer knowledge burden, and attitudes and information about cancer screenings scales after agreeing to participate in the study. They will complete the scales again one month later. The evaluation of the education in the experimental group will involve comparing the scales completed before and after the education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Sep 2024
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2024
CompletedFirst Posted
Study publicly available on registry
August 30, 2024
CompletedStudy Start
First participant enrolled
September 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 10, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2024
CompletedSeptember 3, 2024
August 1, 2024
1 month
August 29, 2024
August 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
İnformation Towards Cancer Screening Scale
The scale consists of 15 items and is unidimensional. It is a five-point Likert scale. The items on the scale are answered on a range from 1 to 5 as follows: \"5: Strongly agree, 4: Agree, 3: Neither agree nor disagree, 2: Disagree, 1: Strongly disagree.\" The scale is suitable for use with men and women aged 30-70 who are at least literate and do not have cognitive, visual, or orthopedic disabilities that would prevent them from answering the scale. The administration method of the scale should be such that the researcher observes the participant, and the participant reads and answers the scale items independently. The scale can be used in any situation where it is necessary to measure attitudes towards cancer screenings, provided that the appropriate sample and administration method are used. The lowest possible score on the scale is 15 and the highest is 75. There is no specific cutoff point for the scale. Scores close to 15 indicate
one month
Secondary Outcomes (2)
Cancer Knowledge Burden
one month
Attitudes Towards Cancer Screening Scale
one mounth
Study Arms (2)
experimental group
OTHERThe effect of cancer education on cancer knowledge burden, information about cancer screenings, and attitudes will be evaluated by providing cancer education to 39 patients in the experimental group.
Control group
NO INTERVENTIONThe control group will not receive any intervention.
Interventions
Participants in the experimental group will receive cancer education.
Eligibility Criteria
You may qualify if:
- Individuals who agree to participate in the study, are aged 30-70,
- Are literate,
- Do not have any auditory, visual, cognitive, or orthopedic disabilities that would prevent participation,
- Are not receiving palliative care services, will be included. This includes caregivers of cancer patients.
You may not qualify if:
- Individuals under the age of 30 or over the age of 70,
- Those who are illiterate,
- Those with disabilities that would prevent participation in the study,
- Those who provide care for cancer patients receiving palliative care services will not be included in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Abdurrhman Yurtaslan Oncology Education and Research Hospital
Ankara, 06200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- nurse
Study Record Dates
First Submitted
August 29, 2024
First Posted
August 30, 2024
Study Start
September 10, 2024
Primary Completion
October 10, 2024
Study Completion
October 28, 2024
Last Updated
September 3, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share